Comparison of Efficacy and Safety of Prandilin and NovoRapid in Newly Diagnosed Type 2 Diabetes

NCT03226210 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: aspart insulin or lipro insulin

Sponsor

Nanjing First Hospital, Nanjing Medical University